Ianthus Capital Holdings Inc
CNSX:IAN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Ianthus Capital Holdings Inc
Net Issuance of Common Stock
Ianthus Capital Holdings Inc
Net Issuance of Common Stock Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
I
|
Ianthus Capital Holdings Inc
CNSX:IAN
|
Net Issuance of Common Stock
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Net Issuance of Common Stock
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Canopy Growth Corp
TSX:WEED
|
Net Issuance of Common Stock
CA$503.6m
|
CAGR 3-Years
488%
|
CAGR 5-Years
12%
|
CAGR 10-Years
28%
|
|
|
Cronos Group Inc
TSX:CRON
|
Net Issuance of Common Stock
-$9.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
|
Net Issuance of Common Stock
$5.7m
|
CAGR 3-Years
-54%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
N/A
|
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Net Issuance of Common Stock
-CA$6.4m
|
CAGR 3-Years
40%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
Ianthus Capital Holdings Inc
Glance View
iAnthus Capital Holdings, Inc. engages in the provision of financing licensed cannabis cultivators, processors, and dispensaries. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2016-09-07. The Company, through its subsidiaries, owns and operates approximately 31 dispensaries and 10 cultivation and/or processing facilities in the United States. In addition, it distributes cannabis and CBD products to over 200 dispensaries and CBD products to over 2,300 retail locations throughout the United States. Its Cannabis products include biomass, products containing biomass, such as pre-rolls, cannabis infused products, such as topical creams and edibles and products containing cannabis extracts, such as vape cartridges, concentrates, live resins, wax products, oils and tinctures. Its CBD products include topical creams, tinctures and sprays and products designed for beauty and skincare.
